{
    "code": "02025454",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025454",
    "time": "2018-11-30 03:04:41",
    "許可證字號": "衛署藥輸字第025454號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/08\/19",
    "發證日期": "100\/08\/19",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202545404",
    "中文品名": "康併莎持續性藥效膜衣錠5毫克\/500毫克",
    "英文品名": "Kombiglyze XR Tablets 5mg\/500mg",
    "適應症": "適用於配合飲食與運動，以改善下列第二型糖尿病患者的血糖控制：已在接受saxagliptin 和 metformin 合併治療者；或僅使用saxagliptin 或 metformin 但控制不佳者。",
    "劑型": "164持續性藥效膜衣錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "METFORMINHYDROCHLORIDEWITH0.5%MAGNESIUMSTEARATE,SAXAGLIPTIN"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1434901100  臺灣阿斯特捷利康股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F460373000  ASTRAZENECA PHARMACEUTICALS LP",
        "製造廠廠址": "4601 HIGHWAY 62 EAST, MOUNT VERNON, INDIANA 47620 USA",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6820400720",
            "成分名稱": "METFORMIN HYDROCHLORIDE WITH 0.5% MAGNESIUM STEARATE",
            "含量描述": "(=metformin hydrochloride 500mg)",
            "含量": "502.5000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "6820802000",
            "成分名稱": "SAXAGLIPTIN",
            "含量描述": "",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Kombiglyze XR Tab 5-500mg, 5-1000mg, 2.5-1000mg 中文仿單-107-10-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025454&Seq=052&Type=9"
        },
        {
            "title": "020254540002___20110930.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025454&Seq=002&Type=8"
        }
    ]
}